HeartSciences annual operating margin
2022
2023
2024
2025
2026
HeartSciences Operating Margin Growth & History (HSCS)
HeartSciences's operating margin was −194,787.38% for fiscal 2026.
View full HeartSciences company overviewHeartSciences annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-04-30 | −194,787.38% | −2774.25 pp |
| 2025 | 2025-04-30 | −192,013.13% | −158111.14 pp |
| 2024 | 2024-04-30 | −33,901.99% | +84796.34 pp |
| 2023 | 2023-04-30 | −118,698.33% | −85932.73 pp |
| 2022 | 2022-04-30 | −32,765.60% | — |
HeartSciences quarterly operating margin
Q1.22
Q3.22
Q4.22
Q1.23
Q3.23
Q2.24
Q3.24
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2025-10-31 | −85,713.23% | — |
| Q1 2026 | 2025-07-31 | −98,637.84% | — |
| Q4 2025 | 2025-04-30 | −44,147.10% | — |
| Q3 2024 | 2024-01-31 | −10,376.75% | +56767.00 pp |
| Q2 2024 | 2023-10-31 | −40,254.95% | — |
| Q3 2023 | 2023-01-31 | −67,143.74% | −26987.28 pp |
| Q1 2023 | 2022-07-31 | −44,690.53% | −35678.69 pp |
| Q4 2022 | 2022-04-30 | −47,669.56% | — |
| Q3 2022 | 2022-01-31 | −40,156.46% | — |
| Q1 2022 | 2021-07-31 | −9,011.84% | — |
HeartSciences operating margin trends
Between the periods ended 2022-04-30 and 2026-04-30, HeartSciences's operating margin decreased from −32,765.60% to −194,787.38%, a change of −162021.79 percentage points. The latest reported quarter, Q2 2026, shows −85,713.23%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HeartSciences source filings ↗